Results 81 to 90 of about 26,546 (243)

A Systematic Review of the Safety and Tolerability of Theta Burst Stimulation in Children and Adolescents

open access: yesNeuromodulation: Technology at the Neural Interface, EarlyView., 2021
Abstract Objectives Theta burst stimulation (TBS) is often used in clinical practice and research protocols for adults with neuropsychiatric disorders. There are substantial knowledge gaps related to the application of TBS in children and adolescents.
Rana Elmaghraby   +5 more
wiley   +1 more source

Efficacy of modified electroconvulsive therapy as augmentation agent in treatment-resistant schizophrenia

open access: yesIndian Journal of Health Sciences and Biomedical Research KLEU
AIM: The aim of the study was to study the efficacy of modified electroconvulsive therapy (MECT) as an augmentation agent in schizophrenia, with particular emphasis in treatment-resistant schizophrenia.
Chitrakshee Singh   +3 more
doaj   +1 more source

Perphenazine in Treatment-Resistant Schizophrenia

open access: yesCureus
Antipsychotics are considered a gold standard treatment for schizophrenia. However, there is considerable variation in antipsychotic medication choice. Factors considered involved include symptomatology, prior response, and adverse reactions. This case report presents a 38-year-old male patient with schizophrenia in acute psychosis refractory to ...
Hower, Michael R   +2 more
openaire   +2 more sources

Latent Profile Analysis of Sleep Patterns in Children With Autism Spectrum Disorder

open access: yesPediatric Discovery, EarlyView.
Children with autism spectrum disorder (ASD) exhibited three distinct sleep phenotypes. Cluster 3, characterized by mild sleep‐disordered breathing, showed significant improvements in core symptoms, whereas Clusters 1 and 2 demonstrated modest changes.
Ke Wang   +9 more
wiley   +1 more source

Prescribing trends in treatment-resistant schizophrenia

open access: yesPsychiatry and Clinical Psychopharmacology, 2017
Objectives: Schizophrenia is a common mental health condition associated with significant morbidity and excess early mortality. Treatment-resistant schizophrenia (TRS) occurs in about one in three patients diagnosed with schizophrenia.
Aynur Görmez   +3 more
doaj   +1 more source

Safety of 12‐Months Administration of Ashwagandha (Withania somnifera) Standardized Root Extract in Healthy Adults: A Prospective, Observational Study

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Ashwagandha, an adaptogen, is an important herb of Ayurveda used as a Rasayana for its various health benefits. This prospective, multi‐center, observational clinical study evaluates the safety (clinical and laboratory) of a standardized Ashwagandha Root Extract (ARE) on long‐term administration over 12 months. Male and female adults (N = 191)
Jaising Salve   +6 more
wiley   +1 more source

G Protein–Coupled Receptors in Olfactory Signaling and Related Disorders: Mechanisms and Therapeutic Implications

open access: yesSensory Neuroscience, EarlyView.
This schematic highlights GPCRs as the central hub of olfactory signaling in health and disease. The central GPCR shows odorant activation and downstream pathways. Surrounding quadrants illustrate four GPCR‐mediated themes: odor perception and adaptation, mucosal immunity and regeneration, memory consolidation via neural circuits, and GPCR‐related ...
Zishuo Guo   +11 more
wiley   +1 more source

Distinguishing Between Treatment-Resistant and Non-Treatment-Resistant Schizophrenia Using Regional Homogeneity

open access: yesFrontiers in Psychiatry, 2018
Background: Patients with treatment-resistant schizophrenia (TRS) and non-treatment-resistant schizophrenia (NTRS) respond to antipsychotic drugs differently. Previous studies demonstrated that patients with TRS or NTRS exhibited abnormal neural activity
Shuzhan Gao   +14 more
doaj   +1 more source

Treatment resistance in Schizophrenia

open access: yesEuropean Psychiatry, 2011
DiagnosisThe diagnosis of treatment resistant schizophrenia generally follows two not always consistent lines of thinking: one is based on research strategies, the other one on every day clinical practice. Both require a failure to respond to at least two (sometimes three) treatment attempts of adequate duration with an adequate dose of an ...
openaire   +1 more source

“Tone‐Arm” Neuromodulation MEMS Microcoil for In Vivo Imaging

open access: yesSmall, EarlyView.
ABSTRACT Implantable neural interfaces have revolutionized neuromodulation by enabling bidirectional communication between neural circuits and external devices. Yet, existing modalities face important challenges in precision, high invasiveness, and compatibility with advanced in vivo imaging systems.
Xiyuan Liu   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy